CMPX (Compass Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

CMPX (Compass Therapeutics, Inc.) Stock Financials & Earnings | Market Cap Arena

CMPXCompass Therapeutics, Inc.

Mkt Cap$781M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$0

Net Income (TTM)-$66M

EPS (TTM)-$0.45

Free Cash Flow (TTM)-$38M

Gross Margin—

Op. Margin—

Net Margin—

FCF Margin—

P/S Ratio (TTM)—

P/E Ratio (TTM)—

YoY Rev Growth-100.0%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$10M
Q2 23	$0	$0	-$13M
Q3 23	$0	$0	-$12M
Q4 23	$0	$0	-$15M
Q1 24	$0	$0	-$13M
Q2 24	$850K	$850K	-$15M
Q3 24	$0	$0	-$12M
Q4 24	$0	$0	-$17M
Q1 25	$0	$0	-$18M
Q2 25	$0	$0	-$21M
Q3 25	$0	$0	-$16M
Q4 25	$0	$0	$0

Valuation

Quarter	P/S	P/E
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	919.2x	—
Q3 24	919.2x	—
Q4 24	919.2x	—
Q1 25	919.2x	—
Q2 25	—	—
Q3 25	—	—
Q4 25	—	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$12M	-$12M
Q2 23	-$10M	-$10M
Q3 23	-$6M	-$6M
Q4 23	-$12M	-$12M
Q1 24	-$14M	-$14M
Q2 24	-$11M	-$11M
Q3 24	-$11M	-$11M
Q4 24	-$9M	-$9M
Q1 25	-$13M	-$13M
Q2 25	-$12M	-$12M
Q3 25	$0	$0
Q4 25	-$13M	-$13M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$11K
Q3 23	$10K
Q4 23	$9K
Q1 24	$0
Q2 24	$0
Q3 24	$44K
Q4 24	$0
Q1 25	$18K
Q2 25	$0
Q3 25	$7K
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	—	+35.2%
Q2 23	—	+48.4%
Q3 23	—	-5.3%
Q4 23	—	+19.4%
Q1 24	—	+31.5%
Q2 24	—	+19.2%
Q3 24	—	+2.6%
Q4 24	—	+7.7%
Q1 25	—	+40.7%
Q2 25	-100.0%	+32.5%
Q3 25	—	+29.2%
Q4 25	—	-100.0%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$1M	—
Q2 23	$2M	—
Q3 23	$2M	—
Q4 23	$2M	—
Q1 24	$2M	—
Q2 24	$2M	249.5%
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$3M	—
Q2 25	$3M	—
Q3 25	$1M	—
Q4 25	$2M	—

OpEx Breakdown

Quarter	R&D	G&A
Q1 23	$7M	$3M
Q2 23	$10M	$3M
Q3 23	$9M	$3M
Q4 23	$12M	$3M
Q1 24	$10M	$3M
Q2 24	$11M	$5M
Q3 24	$9M	$4M
Q4 24	$13M	$4M
Q1 25	$13M	$5M
Q2 25	$16M	$5M
Q3 25	$13M	$3M
Q4 25	$14M	$4M

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$27M	$148M	$175M
Q2 23	$19M	$149M	$169M
Q3 23	$30M	$133M	$164M
Q4 23	$24M	$128M	$152M
Q1 24	$24M	$133M	$156M
Q2 24	$19M	$127M	$146M
Q3 24	$37M	$99M	$135M
Q4 24	$43M	$83M	$127M
Q1 25	$41M	$72M	$113M
Q2 25	$23M	$78M	$101M
Q3 25	$46M	$174M	$220M
Q4 25	$31M	$178M	$209M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	126M	+20.1%
Q2 23	127M	+0.3%
Q3 23	127M	+0.5%
Q4 23	128M	+0.2%
Q1 24	137M	+7.0%
Q2 24	138M	+0.7%
Q3 24	138M	+0.0%
Q4 24	137M	-0.7%
Q1 25	138M	+1.2%
Q2 25	138M	+0.0%
Q3 25	138M	+0.0%
Q4 25	185M	+33.7%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 18	$0	2
FY 19	$0	2
FY 20	$0	31
FY 21	$0	24
FY 22	$0	26
FY 23	$0	32
FY 24	$20K	43
FY 25	$0	39